Clinical Trial Update: 68Ga-PSMA-11 PET in Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on 68Ga-PSMA-11 PET in prostate cancer, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Colorado, Denver | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Phase 3 | Status: COMPLETED | Results posted: 2023-11-13